AI will deliver transformative therapies at an exponential scale, addressing the complexities of biology that traditional ...

This week ended up as a pretty active one for large startup financings. AI and biotech were the biggest areas for funding, ...

In the dynamic world of life sciences, companies face unique challenges in safeguarding their valuable assets. From ...

Ailsa Craig and Marek Poszepczynski, portfolio managers at the International Biotechnology Trust, tell MoneyWeek where they’d ...

Dividend growth investing focuses on acquiring stocks that consistently increase their dividends, providing investors with a ...

Teva Pharma is an Israeli pharmaceutical company best known as one of the world’s largest manufacturers of generic drugs.

Healthpeak’s development projects across its life science portfolio should be completed at development yields above the company's weighted average cost of capital and could drive strong internal ...

Amgen (NASDAQ: AMGN) is doing something unusual in 2025. Here's why this $150 billion pharmaceutical powerhouse deserves a ...

Eli Lilly (NYSE: LLY) has transformed from a steady pharmaceutical giant into one of Wall Street’s standout growth ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

We assign Veeva’s commercial solutions a wide moat based on customer switching costs. Veeva CRM is Veeva’s cloud-based customer relationship management platform. It markets to pharmaceutical and ...

A February executive order on pharmaceutical price transparency does nothing to change the incentives that keep costs opaque. But drug companies and other stakeholders would reap the benefits of such ...